Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 178

1.

Membrane estrogen receptor-alpha levels in MCF-7 breast cancer cells predict cAMP and proliferation responses.

Zivadinovic D, Gametchu B, Watson CS.

Breast Cancer Res. 2005;7(1):R101-12. Epub 2004 Nov 24.

PMID:
15642158
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Membrane estrogen receptor-alpha levels predict estrogen-induced ERK1/2 activation in MCF-7 cells.

Zivadinovic D, Watson CS.

Breast Cancer Res. 2005;7(1):R130-44. Epub 2004 Nov 26.

PMID:
15642162
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.

Gilad LA, Bresler T, Gnainsky J, Smirnoff P, Schwartz B.

J Endocrinol. 2005 Jun;185(3):577-92.

PMID:
15930183
[PubMed - indexed for MEDLINE]
Free Article
5.

Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.

Lee YR, Park J, Yu HN, Kim JS, Youn HJ, Jung SH.

Biochem Biophys Res Commun. 2005 Nov 4;336(4):1221-6.

PMID:
16169518
[PubMed - indexed for MEDLINE]
6.

G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells.

Albanito L, Madeo A, Lappano R, Vivacqua A, Rago V, Carpino A, Oprea TI, Prossnitz ER, Musti AM, Andò S, Maggiolini M.

Cancer Res. 2007 Feb 15;67(4):1859-66.

PMID:
17308128
[PubMed - indexed for MEDLINE]
Free Article
7.

COUP-TFI modulates estrogen signaling and influences proliferation, survival and migration of breast cancer cells.

Le Dily F, Métivier R, Guéguen MM, Le Péron C, Flouriot G, Tas P, Pakdel F.

Breast Cancer Res Treat. 2008 Jul;110(1):69-83. Epub 2007 Aug 3.

PMID:
17674191
[PubMed - indexed for MEDLINE]
8.

Physiologic levels of 2-methoxyestradiol interfere with nongenomic signaling of 17beta-estradiol in human breast cancer cells.

Vijayanathan V, Venkiteswaran S, Nair SK, Verma A, Thomas TJ, Zhu BT, Thomas T.

Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2038-48.

PMID:
16609013
[PubMed - indexed for MEDLINE]
Free Article
9.

Gene regulation in an MCF-7 cell line that naturally expresses an estrogen receptor unable to directly bind DNA.

Pentecost BT, Bradley LM, Gierthy JF, Ding Y, Fasco MJ.

Mol Cell Endocrinol. 2005 Jun 30;238(1-2):9-25.

PMID:
15913882
[PubMed - indexed for MEDLINE]
10.

Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis.

Lewis-Wambi JS, Kim HR, Wambi C, Patel R, Pyle JR, Klein-Szanto AJ, Jordan VC.

Breast Cancer Res. 2008;10(6):R104. doi: 10.1186/bcr2208. Epub 2008 Dec 5.

PMID:
19061505
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.

Menendez JA, Oza BP, Colomer R, Lupu R.

Int J Oncol. 2005 Jun;26(6):1507-15.

PMID:
15870863
[PubMed - indexed for MEDLINE]
12.

Estrogen up-regulates neuropeptide Y Y1 receptor expression in a human breast cancer cell line.

Amlal H, Faroqui S, Balasubramaniam A, Sheriff S.

Cancer Res. 2006 Apr 1;66(7):3706-14.

PMID:
16585197
[PubMed - indexed for MEDLINE]
Free Article
13.

TNF alpha-induced down-regulation of estrogen receptor alpha in MCF-7 breast cancer cells.

Lee SH, Nam HS.

Mol Cells. 2008 Sep 30;26(3):285-90. Epub 2008 May 14.

PMID:
18483465
[PubMed - indexed for MEDLINE]
Free Article
14.

Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.

Jiang J, Slivova V, Sliva D.

Int J Oncol. 2006 Sep;29(3):695-703.

PMID:
16865287
[PubMed - indexed for MEDLINE]
15.

Effect of vinca alkaloids on ERalpha levels and estradiol-induced responses in MCF-7 cells.

Martínez-Campa C, Casado P, Rodríguez R, Zuazua P, García-Pedrero JM, Lazo PS, Ramos S.

Breast Cancer Res Treat. 2006 Jul;98(1):81-9. Epub 2006 Mar 23.

PMID:
16555127
[PubMed - indexed for MEDLINE]
16.

Mechanistic differences in the activation of estrogen receptor-alpha (ER alpha)- and ER beta-dependent gene expression by cAMP signaling pathway(s).

Coleman KM, Dutertre M, El-Gharbawy A, Rowan BG, Weigel NL, Smith CL.

J Biol Chem. 2003 Apr 11;278(15):12834-45. Epub 2003 Jan 31.

PMID:
12566449
[PubMed - indexed for MEDLINE]
Free Article
17.

Epidermal growth factor induces WISP-2/CCN5 expression in estrogen receptor-alpha-positive breast tumor cells through multiple molecular cross-talks.

Banerjee S, Sengupta K, Saxena NK, Dhar K, Banerjee SK.

Mol Cancer Res. 2005 Mar;3(3):151-62.

PMID:
15798095
[PubMed - indexed for MEDLINE]
Free Article
18.

Regulation of MCF-7 breast cancer cell growth by beta-estradiol sulfation.

Falany JL, Macrina N, Falany CN.

Breast Cancer Res Treat. 2002 Jul;74(2):167-76.

PMID:
12186377
[PubMed - indexed for MEDLINE]
19.

Naloxone acts as an antagonist of estrogen receptor activity in MCF-7 cells.

Farooqui M, Geng ZH, Stephenson EJ, Zaveri N, Yee D, Gupta K.

Mol Cancer Ther. 2006 Mar;5(3):611-20.

PMID:
16546975
[PubMed - indexed for MEDLINE]
Free Article
20.

17Beta-estradiol induces down-regulation of Cap43/NDRG1/Drg-1, a putative differentiation-related and metastasis suppressor gene, in human breast cancer cells.

Fotovati A, Fujii T, Yamaguchi M, Kage M, Shirouzu K, Oie S, Basaki Y, Ono M, Yamana H, Kuwano M.

Clin Cancer Res. 2006 May 15;12(10):3010-8.

PMID:
16707596
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk